Device Trial Radar · NCT03715270
Evaluation of Tissue Oxygen Levels During Breast Reconstruction With a New Surgical Device
Last checked: Nov 21, 2026Latest source record: Jun 10, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
6
Actual
Start
Jan 30, 2019
Primary completion
Jun 5, 2019
Study completion Jun 5, 2019
Sponsor
- Lead sponsor
- Christie Medical Holdings, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 23, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the information provided to the clinicians by the surgical imaging device. It is also to gain insight on the user interface and how "user friendly" it is to the clinician.
Conditions
- Perfusion; Complications
Interventions
Image surgical areaDevice
Image surgical area
Primary outcomes
What the sponsor says the trial is designed to measure.
- Photographic, electronic and descriptive comparative analysis of superficial tissue oxygen saturation using Presygen™/si-1 for breast reconstruction subjects.Time frame: 24 hours.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Englewood Hospital and Medical Cetner
Englewood, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.